Anteris Technologies Global Corp. balance sheet
At the end of fiscal 2025, Anteris Technologies Global Corp. had total assets of $23.0m, total liabilities of $23.3m and shareholders' equity of −$93,000. It held $6.7m in cash against $38,000 of debt: net cash of $6.7m.
Balance sheet
| Fiscal year | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|
| Cash and equivalents | 70 | 7 | 250 |
| Receivables | 0 | 0 | 1 |
| Inventory | 1 | 0 | 0 |
| Total current assets | 75 | 16 | 261 |
| Total assets | 81 | 23 | 273 |
| Accounts payable | 6 | 11 | 5 |
| Total current liabilities | 17 | 21 | 18 |
| Long-term debt | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 |
| Total liabilities | 18 | 23 | 21 |
| Shareholders' equity | 63 | −0 | 251 |
| Net debt (negative = net cash) | −70 | −7 | −249 |
| Shares outstanding | — | 42m | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | — | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| Inventory | — | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total current assets | — | 75 | 53 | 32 | 11 | 16 | 287 | 261 |
| Total assets | — | 81 | 59 | 40 | 19 | 23 | 295 | 273 |
| Accounts payable | — | 6 | 5 | 5 | 4 | 11 | 4 | 5 |
| Total current liabilities | — | 17 | 14 | 13 | 13 | 21 | 14 | 18 |
| Long-term debt | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | — | 18 | 16 | 16 | 16 | 23 | 16 | 21 |
| Shareholders' equity | 3 | 63 | 43 | 24 | 4 | −0 | 278 | 251 |
| Shares outstanding | — | 36m | 36m | 36m | 36m | 42m | 97m | 97m |
Compare with peers
- Femasys Inc balance sheet
- Volitionrx LTD balance sheet
- Seastar Medical Holding Corp balance sheet
- Insight Molecular Diagnostics Inc. balance sheet
- Icecure Medical Ltd. balance sheet
Head to head: AVR vs FEMYAVR vs VNRXAVR vs ICU
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies